ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.488
-0.73%
Brent Oil
83.76
0.00%
Bitcoin
66,922.32
-0.03%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Ikena Oncology Inc (IKNA)

  7. Ikena Oncology Inc (IKNA) Noticias

IKNA

Ikena Oncology (IKNA)

Ikena Oncology Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IKNA
FechaHoraFuenteTítuloSímboloCompañía
13/05/202415:45GlobeNewswire Inc.Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
13/05/202415:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
10/04/202407:00GlobeNewswire Inc.Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IKNAIkena Oncology Inc
12/03/202407:00GlobeNewswire Inc.Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
05/03/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
05/03/202415:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
27/02/202407:00GlobeNewswire Inc.Ikena Oncology to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:IKNAIkena Oncology Inc
21/02/202415:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
21/02/202415:15GlobeNewswire Inc.Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical OfficerNASDAQ:IKNAIkena Oncology Inc
18/01/202415:05GlobeNewswire Inc.Ikena Oncology Outlines Key Priorities and Provides Corporate UpdatesNASDAQ:IKNAIkena Oncology Inc
09/11/202306:00GlobeNewswire Inc.Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
07/11/202307:00GlobeNewswire Inc.Ikena Oncology to Present at Multiple November 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
25/09/202315:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:IKNAIkena Oncology Inc
15/09/202315:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:IKNAIkena Oncology Inc
12/09/202315:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IKNAIkena Oncology Inc
10/09/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IKNAIkena Oncology Inc
05/09/202307:00GlobeNewswire Inc.Ikena Oncology to Participate in September 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
18/08/202315:03Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IKNAIkena Oncology Inc
18/08/202315:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IKNAIkena Oncology Inc
10/08/202307:00GlobeNewswire Inc.Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
07/08/202306:00GlobeNewswire Inc.Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock TransactionNASDAQ:IKNAIkena Oncology Inc
13/06/202315:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IKNAIkena Oncology Inc
09/06/202315:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IKNAIkena Oncology Inc
24/05/202307:00GlobeNewswire Inc.Ikena Oncology to Participate in Upcoming Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
15/05/202306:50GlobeNewswire Inc.Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology PipelineNASDAQ:IKNAIkena Oncology Inc
15/05/202306:45GlobeNewswire Inc.Ikena Oncology Announces $40 Million Underwritten OfferingNASDAQ:IKNAIkena Oncology Inc
15/05/202306:27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IKNAIkena Oncology Inc
15/05/202305:36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IKNAIkena Oncology Inc
28/04/202307:25Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:IKNAIkena Oncology Inc
28/04/202307:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IKNAIkena Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:IKNA

Su Consulta Reciente

NASDAQ
FUOAGX
Market Strength Allocati...
NASDAQ
FHNXDX
Cboe Vest Large Cap Deep...
EU
BRAAC
Regiao Autnoma dos Acore...
ASX
XTX
S&P ASX All Technology
NASDAQ
AAZCGXX
Citigroup Global Markets...
BOV
BCLO39R
Global X Funds
LSE
QK56
Morg.st.b.v 25
LSE
58ZK
Newday 26 A
NASDAQ
FQETKX
Cboe Vest Large Cap Deep...
NASDAQ
CCFJX
Principal Equity Income ...
EU
BE0002781624
Region Wallonne 0.196% u...
ASX
AZLOA
Arizona Lithium
LSE
40SO
Municplty 44
LSE
HO75
Malmo 24
NASDAQ
AAYBQXX
Morgan Stanley Finance L...
LSE
CHNA
Csop Srce China
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados